BioSpace News Archive

ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry.

Eli Lilly and Company (NYSE: LLY) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019. David A. Ricks, Lilly’s chairman and chief executive officer, will participate in a fireside chat from 6:00 p.m. to 6:25 p.m. Eastern time.

Bio-Rad Laboratories, Inc. today announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019.

AmerisourceBergen Corporation today announced that it plans to release its results for the First Quarter Fiscal 2019 on Thursday, January 31, 2019, prior to the opening of trading on the New York Stock Exchange.

Calyxt (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused Company, announced today the hiring of William F. (Bill) Koschak, as Chief Financial Officer of Calyxt, effective January 7, 2019. Mr. Koschak will be assuming the responsibilities of current interim CFO, Eric Dutang, who remains CFO of Cellectis, Calyxt’s parent company.

Vizient, Inc. is extremely pleased by the recent ruling made by a federal district court judge that the Department of Health and Human Services (HHS) “exceeded its statutory authority” when the agency reduced Medicare payments to hospitals participating in the 340B Drug Pricing Program by nearly 30 percent.

Considered the kickoff event of the year for the life sciences industry, BioNJ’s 26th Annual Dinner Meeting & Innovation Celebration will take place Thursday, February 7, 2019 at the Hilton East Brunswick.

Senseonics Holdings, Inc. today announced that the extended life Eversense® XL sensor that lasts up to 180 days has been implanted in the first U.S. study participant as part of the clinical trial for pre-market application submission to the Food and Drug Administration.

General Catalyst managing director Hemant Taneja and Jefferson Health CEO Dr. Stephen K. Klasko to join Board of Directors

Global Telehealth Platform Buys Secure Video Conferencing and Electronic Medical Record (EMR) Technology Firm